{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "product_ndc": "65862-105",
      "generic_name": "Efavirenz",
      "labeler_name": "Aurobindo Pharma Limited",
      "brand_name": "Efavirenz",
      "active_ingredients": [
        {
          "name": "EFAVIRENZ",
          "strength": "100 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "65862-105-10",
          "description": "3 BLISTER PACK in 1 CARTON (65862-105-10)  / 10 CAPSULE in 1 BLISTER PACK",
          "marketing_start_date": "20171215",
          "sample": false
        },
        {
          "package_ndc": "65862-105-30",
          "description": "30 CAPSULE in 1 BOTTLE (65862-105-30)",
          "marketing_start_date": "20171215",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Aurobindo Pharma Limited"
        ],
        "rxcui": [
          "205290",
          "205291",
          "205292"
        ],
        "spl_set_id": [
          "4c57ad7f-321a-46c8-851a-c895466eb8e1"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175463",
          "N0000175460",
          "N0000009948",
          "N0000190118",
          "N0000187064",
          "N0000185504",
          "N0000182140",
          "N0000182141"
        ],
        "pharm_class_epc": [
          "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]",
          "Cytochrome P450 3A Inducers [MoA]",
          "Cytochrome P450 2B6 Inducers [MoA]",
          "Cytochrome P450 2C9 Inhibitors [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]",
          "Cytochrome P450 3A4 Inhibitors [MoA]"
        ],
        "unii": [
          "JE6H2O27P8"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20171215",
      "product_id": "65862-105_a02dd4c8-6159-48b0-a79c-c362f1f4daf9",
      "application_number": "ANDA078064",
      "brand_name_base": "Efavirenz",
      "pharm_class": [
        "Cytochrome P450 2B6 Inducers [MoA]",
        "Cytochrome P450 2C19 Inhibitors [MoA]",
        "Cytochrome P450 2C9 Inhibitors [MoA]",
        "Cytochrome P450 3A Inducers [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]",
        "Non-Nucleoside Analog [EXT]",
        "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"
      ]
    }
  ]
}